Literature DB >> 23250300

Changes in incidence of anogenital warts diagnoses after the introduction of human papillomavirus vaccination in Germany-an ecologic study.

Rafael T Mikolajczyk1, Angela A Kraut, Johannes Horn, Renate Schulze-Rath, Edeltraut Garbe.   

Abstract

In a large health insurance database in Germany, incidence of anogenital warts among 15- to 19-year-old females decreased from 316/100,000 person-years in 2007 to 242 in 2008 (23% reduction, P = 0.0001). The decrease started between the first and second quarter of 2007 (human papillomavirus vaccination was introduced in March 2007).

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23250300     DOI： 10.1097/OLQ.0b013e3182756efd

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   2.830


  19 in total

1.  Human Papillomavirus Vaccination and Anogenital Warts: A Systematic Review of Impact and Effectiveness in the United States.

Authors:  Anthony E Yakely; Lital Avni-Singer; Carlos R Oliveira; Linda M Niccolai
Journal:  Sex Transm Dis       Date:  2019-04       Impact factor: 2.830

2.  Incidence of external genital lesions related to human papillomavirus among Mexican men. A cohort study.

Authors:  Eduardo Lazcano-Ponce; Staci L Sudenga; B Nelson Torres; Mark Stoler; Leith León-Maldonado; Betania Allen-Leigh; Héctor Posso; Manuel Quiterio; María Del Pilar Hernández-Nevarez; Jorge Salmerón; Anna R Giuliano
Journal:  Salud Publica Mex       Date:  2018 Nov-Dec

3.  Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.

Authors:  Mélanie Drolet; Élodie Bénard; Norma Pérez; Marc Brisson
Journal:  Lancet       Date:  2019-06-26       Impact factor: 79.321

4.  Effect of the framing of HPV vaccination on parents' willingness to accept an HPV vaccine.

Authors:  Zhuoying Huang; Mengdi Ji; Jia Ren; Xiaodong Sun; Matthew L Boulton; Brian J Zikmund-Fisher; Abram L Wagner
Journal:  Vaccine       Date:  2022-01-04       Impact factor: 3.641

5.  Evaluation of safety and immunogenicity of a quadrivalent human papillomavirus vaccine in healthy females between 9 and 26 years of age in Sub-Saharan Africa.

Authors:  Nelly Mugo; Nana Akosua Ansah; Deborah Marino; Alfred Saah; Elizabeth I O Garner
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 6.  Population impact of HPV vaccines: summary of early evidence.

Authors:  Susan Hariri; Lauri E Markowitz; Eileen F Dunne; Elizabeth R Unger
Journal:  J Adolesc Health       Date:  2013-12       Impact factor: 5.012

Review 7.  Impact of HPV vaccination on anogenital warts and respiratory papillomatosis.

Authors:  Zoon Wangu; Katherine K Hsu
Journal:  Hum Vaccin Immunother       Date:  2016-05-23       Impact factor: 3.452

Review 8.  Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis.

Authors:  Mélanie Drolet; Élodie Bénard; Marie-Claude Boily; Hammad Ali; Louise Baandrup; Heidi Bauer; Simon Beddows; Jacques Brisson; Julia M L Brotherton; Teresa Cummings; Basil Donovan; Christopher K Fairley; Elaine W Flagg; Anne M Johnson; Jessica A Kahn; Kimberley Kavanagh; Susanne K Kjaer; Erich V Kliewer; Philippe Lemieux-Mellouki; Lauri Markowitz; Aminata Mboup; David Mesher; Linda Niccolai; Jeannie Oliphant; Kevin G Pollock; Kate Soldan; Pam Sonnenberg; Sepehr N Tabrizi; Clare Tanton; Marc Brisson
Journal:  Lancet Infect Dis       Date:  2015-03-03       Impact factor: 25.071

Review 9.  Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (gardasil(®)): a review of its use in the prevention of premalignant anogenital lesions, cervical and anal cancers, and genital warts.

Authors:  Paul L McCormack
Journal:  Drugs       Date:  2014-07       Impact factor: 11.431

10.  Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis.

Authors:  Agnieszka Denecke; Thomas Iftner; Angelika Iftner; Sebastian Riedle; Marion Ocak; Alexander Luyten; Isak Üye; Kübra Tunc; Karl Ulrich Petry
Journal:  BMC Infect Dis       Date:  2021-07-02       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.